Donald A. Denkhaus - 08 Jan 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Donald A. Denkhaus
Issuer symbol
CPRX
Transactions as of
08 Jan 2025
Net transactions value
+$112,000
Form type
4
Filing time
10 Jan 2025, 17:00:19 UTC
Previous filing
31 Dec 2024
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common Stock, par value $0.001 per share Options Exercise $112,000 +50,000 +11% $2.24 491,079 08 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -50,000 -24% $0.000000 162,274 08 Jan 2025 Common Stock 50,000 $2.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vested in three equal tranches on December 19, 2019, 2020 and 2021.